Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Thomas Flaig and Eryn Callihan.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.059 |
|
|
|
-
Kessler ER, Callihan E, Hu J, Eule C, Srivastava G, Kemme DJ, Iruku P, Rana V, Moore J, Schuster SR, Amirault M, Flaig TW, Lam ET. A Phase I/II Clinical Trial of Pembrolizumab and Cabozantinib in Metastatic Renal Cell Carcinoma. Cancer Res Commun. 2023 06; 3(6):1004-1012.
Score: 0.059